Arvee Laboratories (India) Ltd. (ARVEE) Share Price Rises 8.87% Today
- August 11, 2026
- Posted by: Harsh Piplani
- Category: News
Arvee Laboratories (India) Ltd. rose to Rs 168.86, up 8.87% today, taking its market capitalisation to Rs 170.92 crore in a notable micro cap move.
Arvee Laboratories (India) Ltd. Share Price climbed to Rs 168.86 on 11 August 2026, up 8.87% from the previous close of Rs 155.10, lifting the company’s market capitalisation to Rs 170.92 crore. That makes the stock one of the notable price rises on the screen today, with the verified data confirming a sharp same-day gain in a micro cap Chemicals name listed on NSE under the symbol ARVEE.
For investors searching Arvee Laboratories (India) Ltd. Share Price Today or Arvee Laboratories (India) Ltd. Stock News, the immediate takeaway is straightforward: the stock opened at Rs 155.10, touched an intraday high of Rs 169.95, and did not fall below its opening level during the session range captured in the supplied data. Turnover stood at Rs 0.09 crore, while NSE volume, current volume and total volume were all 5,463 shares.
The supplied dataset confirms the price event and shows why the stock is trending in market screens today, but it does not establish any company-specific catalyst behind the move. What investors can verify, however, is that the price action was meaningful enough for the stock to be captured under a PRICE_RISE_THRESHOLD event in the Micro Cap category. Univest therefore focuses not on speculation, but on what the numbers actually show: price behaviour, participation, valuation, profitability and sector positioning. Those factors matter when assessing whether Arvee Laboratories (India) Ltd. Share Price deserves continued monitoring after today’s gain.
Arvee Laboratories (India) Ltd. (ARVEE) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 168.86 |
| Previous Close | Rs 155.1 |
| Today's Change | +Rs 13.76 (+8.87%) |
| Day Open | Rs 155.1 |
| Day High | Rs 169.95 |
| Day Low | Rs 155.1 |
| Current Volume (NSE) | 5,463 |
| NSE Traded Volume | 5,463 |
| Combined NSE + BSE Volume | 5,463 |
| Turnover | Rs 0.09 crore |
| Market Capitalisation | Rs 170.92 crore |
| Market Cap Category | Micro Cap |
Arvee Laboratories (India) Ltd. (ARVEE) traded at Rs 168.86. versus the previous close of Rs 155.1, a rise of 8.87%. The stock opened at Rs 155.1, reached Rs 169.95, touched Rs 155.1. Reported volume was 5,463.
Arvee Laboratories (India) Ltd. (ARVEE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 170.92 crore |
| P/E Ratio | 42.22x |
| P/B Ratio | 4.82x |
| ROE | 13.38% |
| ROCE | 15.99% |
| EPS | Rs 3.67 |
| Dividend Yield | 0% |
Arvee Laboratories (India) Ltd. was valued at a P/E ratio of 42.22x, a P/B ratio of 4.82x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of 13.38% and ROCE of 15.99%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Per-share and shareholder-return metrics included EPS of Rs 3.67, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.
Arvee Laboratories (India) Ltd. Fundamental Analysis begins with size and valuation. The company’s market capitalisation stands at Rs 170.92 crore, placing it firmly in the micro cap segment of the Indian stock market. Its price-to-earnings ratio is 42.22 and its price-to-book ratio is 4.82. On profitability, return on equity is 13.38% and return on capital employed is 15.99%.
These numbers create a mixed but measurable fundamental picture. A P/E ratio of 42.22 indicates that the stock is trading at more than 42 times earnings, while a P/B ratio of 4.82 shows the market price stands at a noticeable premium to accounting net worth. Whether that looks demanding or reasonable depends on sector context, which becomes important in the next section. On standalone interpretation, the valuation is not low in absolute terms.
At the same time, profitability is not weak. ROE of 13.38% suggests the business is generating double-digit returns on shareholder equity, while ROCE of 15.99% indicates a comparable level of return on capital employed. For investors reading Arvee Laboratories (India) Ltd. Stock Analysis or Arvee Laboratories (India) Ltd. Fundamental Analysis, those return ratios matter because they help explain why the market may still assign a premium multiple despite the company’s small size.
Univest notes that Arvee Laboratories (India) Ltd. Share Price is drawing attention today primarily because of the 8.87% move, but the stock’s fundamentals also show that the market is valuing the business at a premium to many industry book-value benchmarks. That makes sector and peer comparison essential before taking a broader view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Chemicals |
| Industry | Chemicals |
| Benchmark Scope | same industry |
| Company P/E Ratio | 42.22x |
| Benchmark Median P/E | 23.23x |
| Benchmark Average P/E | 50.18x |
| Benchmark P/E Range | 4.8x to 689.24x |
| Company P/B Ratio | 4.82x |
| Benchmark Median P/B | 1.62x |
| Company ROE | 13.38% |
| Benchmark Median ROE | 11.49% |
| Company ROCE | 15.99% |
| Benchmark Median ROCE | 13.4% |
| Company Market Capitalisation | Rs 170.92 crore |
| Benchmark Median Market Cap | Rs 238.93 crore |
Arvee Laboratories (India) Ltd. (ARVEE) is classified under sector: Chemicals and industry: Chemicals.
Arvee Laboratories (India) Ltd. (ARVEE) has a P/E ratio of 42.22x, which is above the benchmark median of 23.23x, a difference of +81.75%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Arvee Laboratories (India) Ltd. (ARVEE) has a ROE of 13.38%, which is above the benchmark median of 11.49%, a difference of +16.45%. Arvee Laboratories (India) Ltd. (ARVEE) has a ROCE of 15.99%, which is above the benchmark median of 13.4%, a difference of +19.33%.
Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.
The supplied sector snapshot places Arvee Laboratories (India) Ltd. in the Chemicals industry, with benchmarking drawn from the same industry across 141 companies. That gives useful context because today’s share price rise can be compared against a broad valuation and profitability range rather than viewed in isolation.
The company’s P/E ratio of 42.22 sits well above the industry median of 23.23 but below the industry average of 50.18. The range itself is wide, from 4.8 to 689.24 across 114 companies with P/E data, which shows Chemicals valuations vary sharply by business model and earnings profile. On this basis, Arvee Laboratories (India) Ltd. Share Price is not among the lowest-valued names in the sector on earnings, but it is also not trading at the most stretched end of the industry range.
The same pattern is visible on book value. Arvee Laboratories has a P/B ratio of 4.82, compared with an industry median of 1.62 and average of 1.88 across 140 companies. The broader range runs from -64.55 to 47.52, but relative to the median and average, the stock clearly trades at a richer book-value multiple than much of the benchmark group.
Profitability offers a more balanced reading. Company ROE is 13.38%, above the industry median of 11.49% but below the industry average of 14.99%. ROCE at 15.99% is above the industry median of 13.4% and below the average of 17.39%. Market capitalisation at Rs 170.92 crore also sits below the industry median of Rs 238.93 crore and far below the average of Rs 546.98 crore. In short, Univest sees a small-capitalisation Chemicals company with mid-pack profitability metrics but a valuation that screens above typical sector medians. That contrast is important when interpreting today’s top gainer move.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Bhansali Engineering Polymers Ltd. | BEPL | 3,077.13 | 15.69 | 2.73 | 42.11 | 56.88 |
| Chemplast Sanmar Ltd. | CHEMPLASTS | 2,905.26 | 0 | -10.25 | 0 | 183.45 |
| Rossari Biotech Ltd. | ROSSARI | 2,840.33 | 18.74 | 2.07 | 16.17 | 24.37 |
| Nocil Ltd. | NOCIL | 2,824.39 | 42.17 | 1.56 | 12.95 | 17.71 |
| JUBILANT AGRI N CON PRO L | JUBLCPL | 2,780.33 | 21.09 | 5.91 | -12.07 | 16.08 |
Arvee Laboratories (India) Ltd. (ARVEE) has a P/E ratio of 42.22x compared with the displayed peer median of 18.74x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 13.38% compares with a peer median of 12.95% across the companies shown in the table. ROCE stood at 15.99% versus the displayed peer median of 24.37%, providing a capital-efficiency comparison. Arvee Laboratories (India) Ltd. (ARVEE) has a market capitalisation of Rs 170.92 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Peer data shows that Arvee Laboratories (India) Ltd. is much smaller than the larger listed Chemicals names in the supplied comparison set. Its market capitalisation of Rs 170.92 crore is well below Bhansali Engineering Polymers at Rs 3,077.13 crore, Chemplast Sanmar at Rs 2,905.26 crore, Rossari Biotech at Rs 2,840.33 crore, Nocil at Rs 2,824.39 crore and JUBILANT AGRI N CON PRO L at Rs 2,780.33 crore. Even the lower end of the supplied peer list, such as Thirumalai Chemicals at Rs 2,021.67 crore, remains substantially larger.
On valuation, Arvee’s P/E of 42.22 is almost identical to Nocil’s 42.17, higher than Bhansali Engineering Polymers at 15.69, Rossari Biotech at 18.74, JUBILANT AGRI N CON PRO L at 21.09, SH Kelkar at 26.52 and GOCL Corporation at 11.82, but below Camlin Fine Sciences at 86.46 and JG Chemicals at 103.63. This places Arvee Laboratories (India) Ltd. Share Price in the upper middle of the supplied peer valuation spectrum rather than at an outright extreme.
Profitability is mixed relative to peers. ROE of 13.38% is above GOCL Corporation at 7.59%, Camlin Fine Sciences at 10.55%, Nocil at 12.95% and JUBILANT AGRI N CON PRO L at -12.07%, but below Rossari Biotech at 16.17%, SH Kelkar at 15.21%, JG Chemicals at 29.78%, Thirumalai Chemicals at 29.79% and Bhansali Engineering Polymers at 42.11%. ROCE of 15.99% is stronger than SH Kelkar at 9.48%, Camlin Fine Sciences at 11.37% and GOCL Corporation at 6.53%, close to JUBILANT AGRI N CON PRO L at 16.08%, but below Rossari Biotech at 24.37%, JG Chemicals at 29.05%, Thirumalai Chemicals at 35.47%, Nocil at 17.71% and Bhansali Engineering Polymers at 56.88%.
The takeaway from this stock analysis is that Arvee is not the cheapest name versus earnings or book value, nor the strongest on profitability. However, it is also not the weakest operating profile in the peer set. That nuance matters when investors review Arvee Laboratories (India) Ltd. Share Price News after today’s move.
Why Investors Are Watching Arvee Laboratories (India) Ltd.
Investors are watching this stock because the verified data shows a meaningful same-day gain in a micro cap Chemicals company, with the price holding close to the intraday high. For traders scanning Stocks in News, Top Gainers Today and market movers, such moves often attract attention even when no company-specific trigger is established in the dataset.
- Price action: The stock rose 8.87% to Rs 168.86 from Rs 155.10, after opening at Rs 155.10 and touching Rs 169.95.
- Volume: NSE volume, current volume and total volume each stood at 5,463 shares, with turnover of Rs 0.09 crore.
- Valuation: P/E is 42.22 and P/B is 4.82, both important for judging how much optimism is already reflected in the stock price.
- Profitability: ROE of 13.38% and ROCE of 15.99% show the company is generating positive returns, though not at the very top of its peer group.
- Sector context: The company trades above industry median valuation levels in the Chemicals benchmark, while profitability sits around the middle of the pack.
What should investors monitor next? Univest would focus on whether Arvee Laboratories (India) Ltd. Share Price continues to hold closer to Rs 169.95 than to the day’s opening level, and whether future sessions show stronger participation than today’s 5,463 shares. Sector-relative valuation and peer profitability remain central to the story.
About Arvee Laboratories (India) Ltd.
Arvee Laboratories (India) Ltd. operates in the Chemicals sector and Chemicals industry, according to the supplied company classification. While the dataset does not provide a longer business description, the sector tag is still useful because it places the company within a large and diverse listed universe where valuation, profitability and scale can differ sharply across participants.
The industry benchmark supplied for this article covers 141 companies in the same Chemicals space. Within that set, Arvee Laboratories remains relatively small by market capitalisation at Rs 170.92 crore, below the industry median of Rs 238.93 crore and well below the average of Rs 546.98 crore. That indicates the company occupies the smaller end of the listed industry spectrum, which can sometimes lead to sharper day-to-day price movements than seen in larger peers.
For readers tracking Arvee Laboratories (India) Ltd. Latest News, the most concrete business context from the verified data is therefore sectoral rather than narrative. The company belongs to a segment where investors often compare earnings multiples, price-to-book ratios and return metrics closely across peers such as Nocil, Rossari Biotech, Camlin Fine Sciences and Bhansali Engineering Polymers. In that framework, today’s move makes the stock relevant not just as a short-term top gainer, but as a smaller Chemicals name whose market pricing now deserves closer comparison against the wider industry backdrop on Univest.
Track Arvee Laboratories (India) Ltd. Share Price on Univest
Use Arvee Laboratories (India) Ltd. (ARVEE) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.
Readers following Arvee Laboratories (India) Ltd. Share Price, Arvee Laboratories (India) Ltd. Share Price Today and Arvee Laboratories (India) Ltd. Stock News can track the stock in one place on Univest. The platform helps users monitor live share price moves, market capitalisation, valuation ratios such as P/E and P/B, profitability measures including ROE and ROCE, and 52-week market context when available.
Univest also helps investors organise stock analysis around what matters most: daily price action, sector comparison, peer metrics and broader market updates. For a micro cap stock like ARVEE, that structured view is useful because today’s rise can be assessed alongside its fundamentals rather than in isolation. Univest keeps the focus on verified data, not speculation, so users can follow Arvee Laboratories (India) Ltd. Share Price Update with clearer context.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Arvee Laboratories (India) Ltd. Share Price rising today?
Ans. Arvee Laboratories (India) Ltd. Share Price rose 8.87% to Rs 168.86 from the previous close of Rs 155.10. The supplied data confirms the price event and its Micro Cap screen qualification, but does not identify a company-specific catalyst.
What is Arvee Laboratories (India) Ltd. Share Price Today?
Ans. Arvee Laboratories (India) Ltd. Share Price Today is Rs 168.86 in the supplied market update. The stock gained Rs 13.76 in absolute terms, with the day’s range running from Rs 155.10 to Rs 169.95.
How did ARVEE trade during the session?
Ans. ARVEE opened at Rs 155.10, which was also the previous close and the day’s low. It then moved higher to an intraday high of Rs 169.95, with the last traded price at Rs 168.86.
What was the trading volume in Arvee Laboratories (India) Ltd. today?
Ans. The supplied data shows current volume, NSE volume and total volume at 5,463 shares. Turnover stood at Rs 0.09 crore, which gives a basic measure of the rupee value traded during today’s move.
What is the market capitalisation of Arvee Laboratories (India) Ltd.?
Ans. Arvee Laboratories (India) Ltd. has a market capitalisation of Rs 170.92 crore based on the supplied data. That places the company in the Micro Cap category, which is relevant when judging the significance of an 8.87% daily gain.
Is Arvee Laboratories (India) Ltd. expensive compared with its Chemicals industry benchmark?
Ans. On supplied numbers, the stock’s P/E of 42.22 is above the industry median of 23.23 but below the average of 50.18. Its P/B of 4.82 is also above the industry median of 1.62 and average of 1.88.
How profitable is Arvee Laboratories (India) Ltd. based on current data?
Ans. The company’s ROE is 13.38% and ROCE is 15.99%. Those figures sit above the Chemicals industry medians of 11.49% and 13.4%, but below the industry averages of 14.99% and 17.39%.
What does EPS and dividend yield show for Arvee Laboratories (India) Ltd.?
Ans. EPS is Rs 3.67, indicating the earnings attributable to each share in the supplied dataset. Dividend yield is 0, so the current data does not show any meaningful historical cash payout yield supporting the stock.
How does Arvee Laboratories (India) Ltd. compare with Nocil on valuation and returns?
Ans. Arvee Laboratories has a P/E of 42.22, almost the same as Nocil’s 42.17. Arvee’s ROE is 13.38% versus Nocil’s 12.95%, while ROCE is 15.99% compared with Nocil’s 17.71%. The company trades at a P/E ratio of 42.22x.
Why are investors tracking this stock on Univest?
Ans. Investors are tracking the stock on Univest because today’s 8.87% price rise, Rs 170.92 crore market cap and Chemicals sector valuation profile make it a relevant name for price action, peer comparison and market context monitoring.
